nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenobarbital—CHRFAM7A—corpus luteum—polycystic ovary syndrome	0.18	0.225	CbGeAlD
Methylphenobarbital—CHRNA7—corpus luteum—polycystic ovary syndrome	0.146	0.182	CbGeAlD
Methylphenobarbital—CHRFAM7A—ovarian follicle—polycystic ovary syndrome	0.141	0.176	CbGeAlD
Methylphenobarbital—CHRNA7—ovarian follicle—polycystic ovary syndrome	0.114	0.142	CbGeAlD
Methylphenobarbital—CYP2C19—urine—polycystic ovary syndrome	0.0306	0.0382	CbGeAlD
Methylphenobarbital—GRIA2—embryo—polycystic ovary syndrome	0.0209	0.0261	CbGeAlD
Methylphenobarbital—Glutethimide—CYP11A1—polycystic ovary syndrome	0.0132	0.865	CrCbGaD
Methylphenobarbital—GABRA4—pituitary gland—polycystic ovary syndrome	0.0118	0.0147	CbGeAlD
Methylphenobarbital—GRIA2—endocrine gland—polycystic ovary syndrome	0.0107	0.0134	CbGeAlD
Methylphenobarbital—CHRFAM7A—female gonad—polycystic ovary syndrome	0.0105	0.0131	CbGeAlD
Methylphenobarbital—CHRNA7—uterus—polycystic ovary syndrome	0.0104	0.013	CbGeAlD
Methylphenobarbital—CHRFAM7A—endocrine gland—polycystic ovary syndrome	0.00978	0.0122	CbGeAlD
Methylphenobarbital—GRIK2—endocrine gland—polycystic ovary syndrome	0.0097	0.0121	CbGeAlD
Methylphenobarbital—GABRA3—endocrine gland—polycystic ovary syndrome	0.00937	0.0117	CbGeAlD
Methylphenobarbital—CHRNA7—adrenal gland—polycystic ovary syndrome	0.00911	0.0114	CbGeAlD
Methylphenobarbital—CHRNA4—adrenal gland—polycystic ovary syndrome	0.00899	0.0112	CbGeAlD
Methylphenobarbital—GABRA2—adipose tissue—polycystic ovary syndrome	0.00897	0.0112	CbGeAlD
Methylphenobarbital—CHRNA7—female gonad—polycystic ovary syndrome	0.00849	0.0106	CbGeAlD
Methylphenobarbital—GABRA2—adrenal gland—polycystic ovary syndrome	0.00804	0.01	CbGeAlD
Methylphenobarbital—CHRNA7—endocrine gland—polycystic ovary syndrome	0.0079	0.00986	CbGeAlD
Methylphenobarbital—CHRNA4—endocrine gland—polycystic ovary syndrome	0.00779	0.00973	CbGeAlD
Methylphenobarbital—GABRA2—vagina—polycystic ovary syndrome	0.00745	0.00931	CbGeAlD
Methylphenobarbital—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.00635	0.00793	CbGeAlD
Methylphenobarbital—CYP2C19—vagina—polycystic ovary syndrome	0.00543	0.00677	CbGeAlD
Methylphenobarbital—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00508	0.00634	CbGeAlD
Methylphenobarbital—CYP2B6—adrenal gland—polycystic ovary syndrome	0.00458	0.00572	CbGeAlD
Methylphenobarbital—CYP2B6—vagina—polycystic ovary syndrome	0.00425	0.0053	CbGeAlD
Methylphenobarbital—CYP2B6—endocrine gland—polycystic ovary syndrome	0.00397	0.00496	CbGeAlD
Methylphenobarbital—Phenobarbital—CYP1A1—polycystic ovary syndrome	0.00206	0.135	CrCbGaD
Methylphenobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.000882	0.0048	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.000876	0.00477	CbGpPWpGaD
Methylphenobarbital—GABRA3—Orphan transporters—PLAT—polycystic ovary syndrome	0.000873	0.00475	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.00087	0.00474	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000868	0.00472	CbGpPWpGaD
Methylphenobarbital—GABRA2—Orphan transporters—PLAT—polycystic ovary syndrome	0.000858	0.00467	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000852	0.00464	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000845	0.0046	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000839	0.00457	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000838	0.00456	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000838	0.00456	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000828	0.00451	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—NGFR—polycystic ovary syndrome	0.000827	0.0045	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000803	0.00437	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000798	0.00434	CbGpPWpGaD
Methylphenobarbital—GRIA2—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000797	0.00434	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.000783	0.00426	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00078	0.00424	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.000773	0.00421	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000773	0.00421	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00077	0.00419	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.000759	0.00413	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.000746	0.00406	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.000745	0.00406	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000732	0.00398	CbGpPWpGaD
Methylphenobarbital—GABRA1—Orphan transporters—PLAT—polycystic ovary syndrome	0.000731	0.00398	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000726	0.00395	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	0.000724	0.00394	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.000714	0.00389	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000714	0.00389	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000709	0.00386	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neuronal System—DLG4—polycystic ovary syndrome	0.000706	0.00384	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000705	0.00384	CbGpPWpGaD
Methylphenobarbital—GRIA2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000705	0.00383	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000696	0.00379	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.000684	0.00372	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000683	0.00372	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000682	0.00371	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00068	0.0037	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000673	0.00366	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.000672	0.00365	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000664	0.00361	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000663	0.00361	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00066	0.00359	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000655	0.00357	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000654	0.00356	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—DLG4—polycystic ovary syndrome	0.000642	0.0035	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000639	0.00348	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000638	0.00347	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000637	0.00347	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.000636	0.00346	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000634	0.00345	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000629	0.00343	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000626	0.00341	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000618	0.00337	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000611	0.00332	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000607	0.0033	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000597	0.00325	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000592	0.00322	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000586	0.00319	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000581	0.00316	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000579	0.00315	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000578	0.00314	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—IRS2—polycystic ovary syndrome	0.000577	0.00314	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000571	0.00311	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.000563	0.00306	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000561	0.00305	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000559	0.00304	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000553	0.00301	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000549	0.00299	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—DLG4—polycystic ovary syndrome	0.00054	0.00294	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00054	0.00294	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000538	0.00293	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000535	0.00291	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000528	0.00287	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—DLG4—polycystic ovary syndrome	0.000524	0.00285	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000514	0.0028	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000514	0.0028	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000509	0.00277	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000508	0.00276	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000505	0.00275	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—IRS1—polycystic ovary syndrome	0.000504	0.00274	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000502	0.00273	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000501	0.00273	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000497	0.00271	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000496	0.0027	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000495	0.0027	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000478	0.0026	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00047	0.00256	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.000468	0.00255	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00046	0.0025	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—DLG4—polycystic ovary syndrome	0.000449	0.00244	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000445	0.00242	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—DLG4—polycystic ovary syndrome	0.000443	0.00241	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.000442	0.00241	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000439	0.00239	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000437	0.00238	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000434	0.00236	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000433	0.00236	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00043	0.00234	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000423	0.0023	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000407	0.00221	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000405	0.0022	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000399	0.00217	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000399	0.00217	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—DLG4—polycystic ovary syndrome	0.000394	0.00214	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000389	0.00212	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—DLG4—polycystic ovary syndrome	0.000387	0.0021	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000383	0.00209	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—DLG4—polycystic ovary syndrome	0.00038	0.00207	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000367	0.00199	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000362	0.00197	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000361	0.00197	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000358	0.00195	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000356	0.00194	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000355	0.00193	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.00034	0.00185	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000332	0.0018	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000328	0.00178	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000327	0.00178	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—DLG4—polycystic ovary syndrome	0.000324	0.00176	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000324	0.00176	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000315	0.00171	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000302	0.00164	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000294	0.0016	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.00029	0.00158	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000286	0.00156	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000282	0.00153	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000277	0.00151	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000274	0.00149	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000273	0.00149	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000269	0.00147	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000266	0.00145	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000263	0.00143	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000249	0.00135	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000249	0.00135	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000247	0.00135	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000244	0.00133	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000244	0.00133	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000235	0.00128	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000233	0.00127	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000231	0.00125	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000229	0.00125	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000227	0.00124	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000226	0.00123	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000225	0.00123	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000223	0.00122	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000217	0.00118	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000216	0.00118	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000213	0.00116	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000213	0.00116	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000209	0.00114	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000208	0.00113	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—NMNAT3—polycystic ovary syndrome	0.000203	0.0011	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000198	0.00108	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000198	0.00108	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000195	0.00106	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000192	0.00105	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000192	0.00104	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000192	0.00104	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.00019	0.00103	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000189	0.00103	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000187	0.00102	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—LPCAT2—polycystic ovary syndrome	0.000185	0.00101	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—SUOX—polycystic ovary syndrome	0.000185	0.00101	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000179	0.000972	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000174	0.000948	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000172	0.000938	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—POMC—polycystic ovary syndrome	0.000172	0.000935	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000172	0.000935	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000172	0.000934	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000167	0.000906	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000164	0.00089	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000163	0.000889	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000161	0.000875	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00016	0.000872	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—NMNAT3—polycystic ovary syndrome	0.000153	0.000834	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—AKR1C2—polycystic ovary syndrome	0.000147	0.000798	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—TEAD2—polycystic ovary syndrome	0.000147	0.000798	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000146	0.000795	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000143	0.000777	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—LPCAT2—polycystic ovary syndrome	0.00014	0.000763	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—SUOX—polycystic ovary syndrome	0.00014	0.000763	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000138	0.000753	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000137	0.000746	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—ISYNA1—polycystic ovary syndrome	0.00013	0.000709	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—POMC—polycystic ovary syndrome	0.00013	0.000707	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000127	0.000693	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000123	0.000669	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000119	0.000647	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000119	0.000646	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000116	0.000634	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000113	0.000614	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—STAR—polycystic ovary syndrome	0.000111	0.000605	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—TEAD2—polycystic ovary syndrome	0.000111	0.000603	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—AKR1C2—polycystic ovary syndrome	0.000111	0.000603	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000107	0.00058	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000105	0.000571	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—HMMR—polycystic ovary syndrome	9.9e-05	0.000539	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—HSD3B1—polycystic ovary syndrome	9.45e-05	0.000514	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	9.28e-05	0.000505	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	8.8e-05	0.000479	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—LHB—polycystic ovary syndrome	8.61e-05	0.000469	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—HSD3B2—polycystic ovary syndrome	8.42e-05	0.000458	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	8.4e-05	0.000457	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	8.3e-05	0.000452	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—AKR1C1—polycystic ovary syndrome	8.15e-05	0.000444	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—SULT2A1—polycystic ovary syndrome	7.5e-05	0.000408	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	7.48e-05	0.000407	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—RRM2—polycystic ovary syndrome	7.27e-05	0.000396	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	7.14e-05	0.000388	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.06e-05	0.000384	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—YAP1—polycystic ovary syndrome	7.01e-05	0.000381	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—NAMPT—polycystic ovary syndrome	6.73e-05	0.000366	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	6.69e-05	0.000364	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CYP11A1—polycystic ovary syndrome	6.65e-05	0.000362	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	6.51e-05	0.000354	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	6.36e-05	0.000346	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—AKR1C3—polycystic ovary syndrome	6.28e-05	0.000342	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CYP17A1—polycystic ovary syndrome	6.18e-05	0.000336	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	6.16e-05	0.000335	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	5.67e-05	0.000309	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	5.49e-05	0.000299	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—TH—polycystic ovary syndrome	5.35e-05	0.000291	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	5.29e-05	0.000288	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—SLC2A4—polycystic ovary syndrome	5.2e-05	0.000283	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	5.09e-05	0.000277	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.06e-05	0.000275	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	5.02e-05	0.000273	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.99e-05	0.000271	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CYP19A1—polycystic ovary syndrome	4.89e-05	0.000266	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	4.74e-05	0.000258	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	4.67e-05	0.000254	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	4.37e-05	0.000238	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	4.16e-05	0.000226	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—TH—polycystic ovary syndrome	4.04e-05	0.00022	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	3.94e-05	0.000215	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	3.93e-05	0.000214	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	3.7e-05	0.000201	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	3.68e-05	0.0002	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	3.3e-05	0.00018	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	3.14e-05	0.000171	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	2.98e-05	0.000162	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	2.98e-05	0.000162	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	2.94e-05	0.00016	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—INS—polycystic ovary syndrome	2.92e-05	0.000159	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	2.78e-05	0.000151	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	2.25e-05	0.000123	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	2.22e-05	0.000121	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—INS—polycystic ovary syndrome	2.21e-05	0.00012	CbGpPWpGaD
